Amarin Corp Plcuk (AMRN) Net Margin (2013 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Net Margin of 23.29% for Q1 2026, up 1407.0% YoY from 1.55% in Q1 2025, and down 836.6% sequentially from 2.49% in Q4 2025.

Amarin Corp Plcuk (AMRN) Net Margin (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Net Margin across 14 years of filings, most recently posting 23.29% for Q1 2026.

  • In Q1 2026, Net Margin rose 1407.0% year-over-year to 23.29%; the TTM figure through Mar 2026 stood at 15.51% (up 2556.0% YoY), while the FY2025 annual figure was 18.16%, up 1779.0% from the prior year.
  • Net Margin fell to 23.29% in Q1 2026, from 2.49% in the prior quarter.
  • Over the last five years, Net Margin for AMRN reached as high as 2.26% in Q2 2024 and fell as low as 78.03% in Q4 2024.
  • The 5-year median for Net Margin is 19.44% (2025), against an average of 25.95%.
  • Annual changes were most pronounced in 2022 — Net Margin sank 7913 bps — and 2025, when it jumped 7554 bps.
  • A 5-year view of Net Margin shows it stood at 0.95% in 2022, then tumbled by 916 bps to 7.74% in 2023, then sank by 908 bps to 78.03% in 2024, then surged by 97 bps to 2.49% in 2025, then slumped by 837 bps to 23.29% in 2026.
  • According to Business Quant data, Net Margin over the past three periods registered 23.29%, 2.49%, and 15.58% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 37.36%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 21.76%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 4.65%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 329.02%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -25.84%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 21.11%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 29.04%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -0.56%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -23.29%

Historic Data

Download Data
DateValue
Mar 31, 2026 -23.29%
Dec 31, 2025 -2.49%
Sep 30, 2025 -15.58%
Jun 30, 2025 -19.44%
Mar 31, 2025 -37.36%
Dec 31, 2024 -78.03%
Sep 30, 2024 -59.42%
Jun 30, 2024 2.26%
Mar 31, 2024 -17.61%
Dec 31, 2023 -7.74%
Sep 30, 2023 -29.23%
Jun 30, 2023 -21.90%
Mar 31, 2023 -19.15%
Dec 31, 2022 0.95%
Sep 30, 2022 -5.72%
Jun 30, 2022 -74.07%
Mar 31, 2022 -33.35%
Dec 31, 2021 10.17%
Sep 30, 2021 -9.26%
Jun 30, 2021 5.05%